Bl Aesthetics Profile
Key Indicators
- Authorised Capital ₹ 5.50 M
- Paid Up Capital ₹ 2.60 M
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.55 M
- Revenue Growth 171.74%
- Profit Growth -85.59%
- Ebitda -92.38%
- Net Worth -184.61%
- Total Assets 171.50%
About Bl Aesthetics
Bl Aesthetics Private Limited (BAPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 December 2019 (Five years and two months 8 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.50 M and a paid-up capital of Rs 2.60 M.
The company currently has active open charges totaling ₹5.55 M.
Sunil Aggarwal, Shubham Aggarwal, and Aashna Aggarwal serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U33309DL2019PTC359100
- Company No.
359100
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Dec 2019
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Bl Aesthetics?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Aggarwal  | Director | 28-Oct-2020 | Current |
| Shubham Aggarwal | Director | 20-Dec-2019 | Current |
| Aashna Aggarwal | Director | 20-Dec-2019 | Current |
Financial Performance of Bl Aesthetics.
Bl Aesthetics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 171.74% increase. The company also saw a substantial fall in profitability, with a 85.59% decrease in profit. The company's net worth observed a substantial decline by a decrease of 184.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bl Aesthetics?
In 2021, Bl Aesthetics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Plastx Labs Private LimitedSunil Aggarwal is a mutual person
B L Lifesciences Private LimitedSunil Aggarwal and Shubham Aggarwal are mutual person
Charges (Loans)
₹5.55 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.55 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Feb 2022 | Hdfc Bank Limited | ₹5.55 M | Open |
How Many Employees Work at Bl Aesthetics?
Unlock and access historical data on people associated with Bl Aesthetics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bl Aesthetics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bl Aesthetics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.